ArticleCancer research and treatment2024

Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations.

Anouk Lindley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.